Antigen-binding protein and use thereof
Patent Information
- Application Number
- HK62026126351
- Authority / Receiving Office
- HK · HK
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-12-01
- Filing Date
- 2026-07-20
- Publication Date
- 2026-09-11
Smart Images

Figure 00000000_0000_ABST
Abstract
Description
(19) State Intellectual Property Office (12) Invention Patent Application (10) Application Publication Number (43) Application Publication Date (21) Application Number 202480076103.8 (22) Application Date 2024.12.02 (66) Domestic Priority Data 202311639416.3 2023.12.01 CN (85) PCT International Application Entering National Phase Date 2026.06.01 (86) PCT International Application Application Data PCT / CN2024 / 136085 2024.12.02 (87) PCT International Application Publication Data WO2025 / 113702 ZH 2025.06.05 (71) Applicant Minghui Pharmaceutical (Hangzhou) Co., Ltd. Address 310018 Room 4-401, Hexiang Technology Center, Qiantang New District, Hangzhou, Zhejiang Province Applicant: Minghui Pharmaceutical (Shanghai) Co., Ltd. (72) Inventors: Liu Bo, Zhu Liyuan, Cao Guoqing, Shi Junwei, Weng Xialian, Cao Yuting (74) Patent Agency: China Council for the Promotion of International Trade Patent & Trademark Office Co., Ltd. 11038 Patent Attorney: Kong Xi (51) Int.Cl. C07K 16 / 30 (2006.01) C07K 16 / 28 (2006.01) A61K 39 / 395 (2006.01) A61P 35 / 00 (2006.01) (54) Invention Title: Antigen-Binding Protein and Its Use (57) Abstract: A nanobody that specifically binds to HER2 or an antigen-binding fragment thereof, a composition containing said nanobody or an antigen-binding fragment thereof, and a nucleic acid molecule encoding said antibody or antigen-binding fragment thereof. In addition, the application of said nanobody or antigen-binding fragment thereof in the treatment and diagnosis of diseases is also involved. CN 122374341 A 2026.07.10 CN 1 22 37 43 41 A
